| For: | Monnier J, Piquet-Pellorce C, Feige JJ, Musso O, Clément B, Turlin B, Théret N, Samson M. Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma. World J Gastroenterol 2008; 14(8): 1182-1191 [PMID: 18300343 DOI: 10.3748/wjg.14.1182] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i8/1182.htm |
| Number | Citing Articles |
| 1 |
Justin Monnier, Michel Samson. Cytokine properties of prokineticins. The FEBS Journal 2008; 275(16) doi: 10.1111/j.1742-4658.2008.06559.x
|
| 2 |
Jean-Jacques Von Hunolstein, Canan G. Nebigil. Can prokineticin prevent obesity and insulin resistance?. Current Opinion in Endocrinology, Diabetes & Obesity 2015; 22(5) doi: 10.1097/MED.0000000000000185
|
| 3 |
S Lauttia, H Sihto, H Kavola, V Koljonen, T Böhling, H Joensuu. Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma. British Journal of Cancer 2014; 110(6) doi: 10.1038/bjc.2014.20
|
| 4 |
Roberta Lattanzi, Cinzia Severini, Rossella Miele. Prokineticin 2 in cancer-related inflammation. Cancer Letters 2022; 546 doi: 10.1016/j.canlet.2022.215838
|
| 5 |
Qiao-Hong Zhao, Xi-Shan Zhang, Kun Wu, Jie Zhang, Tian-Fang Xia, Jian Chen, Zhen-Shen Qin, Li-Qun Pang. Preparation of Zoledronate liposome and its impact on apoptosis of Kupffer cells in rat liver. Acta Cirurgica Brasileira 2018; 33(12) doi: 10.1590/s0102-865020180120000002
|
| 6 |
Célia Guilini, Kyoji Urayama, Gulen Turkeri, Deniz B. Dedeoglu, Hitoshi Kurose, Nadia Messaddeq, Canan G. Nebigil. Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration. American Journal of Physiology-Heart and Circulatory Physiology 2010; 298(3) doi: 10.1152/ajpheart.00898.2009
|
| 7 |
Inga A. Nikitina, Valeria A. Razenkova, Olga V. Kirik, Dmitrii E. Korzhevskii. Visualisation of kupffer cells in the rat liver with poly- and monoclonal antibodies against microglial-specific protein Iba-1. Medical academic journal 2023; 23(1) doi: 10.17816/MAJ133649
|
| 8 |
Martina Vincenzi, Amin Kremić, Appoline Jouve, Roberta Lattanzi, Rossella Miele, Mohamed Benharouga, Nadia Alfaidy, Stephanie Migrenne-Li, Anumantha G. Kanthasamy, Marimelia Porcionatto, Napoleone Ferrara, Igor V. Tetko, Laurent Désaubry, Canan G. Nebigil. Therapeutic Potential of Targeting Prokineticin Receptors in Diseases. Pharmacological Reviews 2023; 75(6) doi: 10.1124/pharmrev.122.000801
|
| 9 |
Mingming Jin, Shengjie Lu, Yue Wu, Chen Yang, Chunzi Shi, Yanqiu Wang, Gang Huang. RETRACTED ARTICLE: Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01697-6
|
| 10 |
Bing He, Hao Zhang, Tieliu Shi, Syed A. Aziz. A Comprehensive Analysis of the Dynamic Biological Networks in HCV Induced Hepatocarcinogenesis. PLoS ONE 2011; 6(4) doi: 10.1371/journal.pone.0018516
|
| 11 |
Canan G. Nebigil. Updates on Endothelial Functions of Proangiogenic Prokineticin. Hypertension 2016; 68(5) doi: 10.1161/HYPERTENSIONAHA.116.08037
|
| 12 |
Justin Monnier, Michel Samson. Prokineticins in angiogenesis and cancer. Cancer Letters 2010; 296(2) doi: 10.1016/j.canlet.2010.06.011
|
| 13 |
Xiaoyan Yu, Jingyi Chen, Hong Tang, Qianqian Tu, Yue Li, Xi Yuan, Xuemei Zhang, Ju Cao, David Paul Molloy, Yibing Yin, Dapeng Chen, Zhixin Song, Pingyong Xu. Identifying Prokineticin2 as a Novel Immunomodulatory Factor in Diagnosis and Treatment of Sepsis*. Critical Care Medicine 2022; 50(4) doi: 10.1097/CCM.0000000000005335
|
| 14 |
Cecilia Martin, Ravikumar Balasubramanian, Andrew A. Dwyer, Margaret G. Au, Yisrael Sidis, Ursula B. Kaiser, Stephanie B. Seminara, Nelly Pitteloud, Qun-Yong Zhou, William F. Crowley. The Role of the Prokineticin 2 Pathway in Human Reproduction: Evidence from the Study of Human and Murine Gene Mutations. Endocrine Reviews 2011; 32(2) doi: 10.1210/er.2010-0007
|
| 15 |
Otto Strauss, P. Rod Dunbar, Adam Bartlett, Anthony Phillips. The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver – A systematic review. Journal of Hepatology 2015; 62(2) doi: 10.1016/j.jhep.2014.10.006
|
| 16 |
Min-Hua Wu, Pei-Ru Wu, Yi-Hsien Hsieh, Chia-Liang Lin, Chung-Jung Liu, Tsung-Ho Ying. Silencing PROK2 Inhibits Invasion of Human Cervical Cancer Cells by Targeting MMP15 Expression. International Journal of Molecular Sciences 2020; 21(17) doi: 10.3390/ijms21176391
|
| 17 |
Ana Paula Abreu, Sekoni D. Noel, Shuyun Xu, Rona S. Carroll, Ana Claudia Latronico, Ursula B. Kaiser. Evidence of the Importance of the First Intracellular Loop of Prokineticin Receptor 2 in Receptor Function. Molecular Endocrinology 2012; 26(8) doi: 10.1210/me.2012-1102
|
| 18 |
Si Mohamed Bouzoubaa, Mohammed Benlahfid, Mustapha Sidqui, Touria Aboussaouira, Chouaib Rifki, Sophie Brouillet, Wael Traboulsi, Nadia Alfaidy, Mohamed Benharouga. Vascular endothelial growth factor (VEGF) and Endocrine gland‐VEGF (EG‐VEGF) are down regulated in head and neck cancer. Clinical Otolaryngology 2020; 45(5) doi: 10.1111/coa.13595
|
| 19 |
Yu Yoshida, Takanori Goi, Hidetaka Kurebayashi, Mitsuhiro Morikawa, Yasuo Hirono, Kanji Katayama. Prokineticin 2 expression as a novel prognostic biomarker for human colorectal cancer. Oncotarget 2018; 9(53) doi: 10.18632/oncotarget.25706
|